Bioperfectus Acquired ISO 9001:2015 Certification

Company news

Shanghai, China, March 25th, 2022—As one of the leading in-vitro diagnostic manufacturers on infectious diseases globally, Bioperfectus solemnly announced that we acquired ISO 9001: 2015 Certification.


It is another recognition of our company quality management system in the international stage besides ISO 13485.”, said Bioperfectus International Sales & Marketing Division Deputy General Manager.


Bioperfectus has formerly obtained ISO 13485, which sets for medical devices company in the quality management system for regulatory purpose. The objective of ISO 9001 is to provide a set of requirements that, if effectively implemented, will give the endorsement of the company’s products and services:

  •  Meet customers’ needs and expectations
  •  Comply with applicable regulations



About ISO 9001: 2015 Certification

ISO 9001 is an International Standard that gives an organization’s quality management system (QMS) requirements. It is part of a family of standards published by the International Organization for Standardization (ISO) and often referred to collectively as theISO 9000 series” or “ISO 9000 family”. To learn more, please click here 

About Bioperfectus

Bioperfectus, a public listed company at Shanghai Stock Exchange (SSE:688399), has been one of the leading molecular diagnostic solution providers specialized in infectious diseases ever since 2010. With headquarters located in Jiangsu, subsidiaries in Shanghai, Beijing, Xi'an, Taizhou, Hainan, and Yinchuan. Bioperfectus is pioneering in the molecular diagnostics market with our products ranging from real-time PCR kits, nucleic acid extraction systems, rapid tests, and automation laboratory devices. Young and passionate, Bioperfectus people are working steadily and firmly to achieve our dream to create a healthier future for our next generations. 


Value of a Catch-up HPV Test in Women Aged 65 and Above: A Danish Population-Based Nonrandomized Intervention Study

In July 2023, Mette Tranberg and others published a study titled "Value of a catch-up HPV test in women aged 65 and above: A Danish population-based nonrandomized intervention study" in the "PLOS Medicine" journal with an impact factor of 15.8.


What You Should Know About the Four Common Sexually Transmitted Diseases

Sexually transmitted diseases (STDs) are quite prevalent, and many individuals infected with STDs may not display any noticeable symptoms.


Dengue Will “Take Off” in Southern Europe, US, Africa This Decade, WHO Scientist Says

Dengue fever will become a major threat in the southern United States, southern Europe, and new parts of Africa this decade, the WHO's chief scientist said, as warmer temperatures create the conditions for the mosquitoes carrying the infection to spread.